Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study.
第一作者:
Gokmen,Aktas
第一单位:
Gaziantep University, School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Gaziantep Oncology Hospital, Gaziantep, Turkey.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);癌, 肝细胞(Carcinoma, Hepatocellular);化学栓塞, 治疗性(Chemoembolization, Therapeutic);综合疗法(Combined Modality Therapy);女(雌)性(Female);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);回顾性研究(Retrospective Studies)
PMID
28365948
发布时间
2018-12-02
- 浏览10
Journal of B.U.ON.
150-156页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



